Highly water-soluble mast cell stabiliser-encapsulated solid lipid nanoparticles with enhanced oral bioavailability

References

• Abdelbary G, Fahmy RH. Diazepam-loaded solid lipid nanoparticles: Design and characterization. AAPS PharmSciTech Sci, 2009;10:211–19.
   PubMed Web of Science ®Google Scholar
• Alani AWG, Robinson JR. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative. Pharm Res, 2008;25:48–54.
   PubMed Web of Science ®Google Scholar
• Attama AA, Momoh MA, Builders PF. 2012. Lipid nanoparticulate drug delivery systems: A revolution in dosage form design and development. In: Sezer AD, ed. Recent advances in novel drug carrier systems. Chapter 5. Europe: InTech. doi: 10.5772/50486.
   Google Scholar
• Barthe L, Woodley JF, Kenworthy S, Houin G. An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur J Drug Metab Pharmacokinet, 1998;23:313–23.
   PubMed Web of Science ®Google Scholar
• Chalikwar SS, Belgamwar VS, Talele VR, Surana SJ, Patil MU. Formulation and evaluation of nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloids Surf B Biointerfaces, 2012;97:109–16.
   PubMed Web of Science ®Google Scholar
• Chaubey P, Patel RR, Mishra B. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Expert Opin Drug Deliv, 2014;11:1163–81.
   PubMed Web of Science ®Google Scholar
• Chaurasia S, Chaubey P, Patel RR, Kumar N, Mishra B. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: Cytotoxicity, pharmacokinetic and anticancer efficacy studies. Drug Dev Ind Pharm, 2015b. [Epub ahead of print]. doi: 10.3109/03639045.2015.1064941.
   PubMed Web of Science ®Google Scholar
• Chaurasia S, Kumar N, Patel RR, Mishra B. Optimization of parameters for the fabrication of curcumin loaded polymeric nanoparticles using taguchi robust design. Adv Sci Lett, 2014;20:1028–38.
   Google Scholar
• Chaurasia S, Patel RR, Chaubey P, Kumar N, Khan G, Mishra B. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin. Carbohydr Polym, 2015a;130:9–17.
   PubMed Web of Science ®Google Scholar
• Deshmukh DD, Ravis WR, Betageri GV. Improved delivery of cromolyn from oral proliposomal beads. Int J Pharm, 2008;358:128–36.
   PubMed Web of Science ®Google Scholar
• Ding X, Rath P, Angelo R, Stringfellow T, Flanders E, Dinh S, Gomez-Orellana I, Robinson JR. Oral absorption enhancement of cromolyn sodium through noncovalent complexation. Pharm Res, 2004;21:2196–206.
   PubMed Web of Science ®Google Scholar
• Florence AT. The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual. Pharm Res, 1997;14:259–66.
   PubMed Web of Science ®Google Scholar
• Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN) dispersions. Int J Pharm, 1998;168:221–9.
   Web of Science ®Google Scholar
• Gajra B, Dalwadi C, Patel RR. Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (lipomer) using Box Behnken design. Daru, 2015a;23:3.
   PubMed Web of Science ®Google Scholar
• Gajra B, Patel RR, Dalwadi C. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design. Drug Dev Ind Pharm, 2015b. [Epub ahead of print]. doi: 10.3109/03639045.2015.1093496.
   PubMedGoogle Scholar
• Gannu R, Yamsani VV, Yamsani SK, Palem CR, Yamsani MR. Optimization of hydrogels for transdermal delivery of Lisinopril by Box-Behnken statistical design. AAPS PharmSciTech Sci, 2009;10:505–14.
   PubMed Web of Science ®Google Scholar
• Huang M, Ma Z, Khor E, Lim LY. Uptake of FITC-chitosan nanoparticles by A549 cells. Pharm Res, 2002;19:1488–94.
   PubMed Web of Science ®Google Scholar
• Joshi G, Kumar A, Sawant K. Enhanced bioavailability and intestinal uptake of gemcitabine HCL loaded PLGA nanoparticles after oral delivery. Eur J Pharm Sci, 2014;60:80–9.
   PubMed Web of Science ®Google Scholar
• Kaartenin M, Pentilla A, Kovanen PT. Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. Arterioscler Thromb, 1994;14:966–72.
   PubMedGoogle Scholar
• Kumar N, Chaurasia S, Patel RR, Khan G, Kumar V, Mishra B. Atorvastatin calcium encapsulated eudragit nanoparticles with enhanced oral bioavailability, safety and efficacy profile. Pharm Dev Tech, 2015. [Epub ahead of print]. doi:10.3109/10837450.2015.1108983.
   Google Scholar
• Kumar N, Chaurasia S, Patel RR, Kumar V, Mishra B. Development and optimization of atorvastatin calcium loaded oral biodegradable polymeric nanoparticles using central composite design. Adv Sci Lett, 2014;20:984–93.
   Google Scholar
• Leroux J, Allemann E, Doelker E, Gurny R. New approach for the preparation of nanoparticles by an emulsification-diffusion method. Eur J Pharm Biopharm, 1995;41:14–18.
   Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, Zhong Z, Zhang Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterization. Int J Pharm, 2007;340:153–62.
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 2001;47:165–96.
   PubMed Web of Science ®Google Scholar
• Mendes AI, Silva AC, Catita JAM, Cerqueira F, Gabriel C, Lopes CM. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: Improving antifungal activity. Colloids Surf B, 2013;111:755–63.
   PubMed Web of Science ®Google Scholar
• Nolan LM, Li J, Tajber L, Corrigan OI, Healy AM. Particle engineering of materials for oral inhalation by dry powder inhalers. I-particles of sugar excipients (trehalose and raffinose) for protein delivery. Int J Pharm, 2011;405:36–46.
   PubMed Web of Science ®Google Scholar
• Patel RR, Chaurasia S, Khan G, Chaubey P, Kumar N, Mishra B. Cromolyn sodium encapsulated PLGA nanoparticles: An attempt to improve intestinal permeation. Int J Biol Macromol, 2016;83:249–58.
   PubMed Web of Science ®Google Scholar
• Patel RR, Khan G, Chaurasia S, Kumar N, Mishra B. Rationally developed core–shell polymeric-lipid hybrid nanoparticles as a delivery vehicle for cromolyn sodium: Implications of lipid envelop on in vitro and in vivo behaviour of nanoparticles upon oral administration. RSC Adv, 2015;5:76491–506.
   Web of Science ®Google Scholar
• Patel RR, Kumar N, Khan G, Chaurasia S, Mishra B. Investigation of critical variables of core-shell polymer lipid hybrid nanoparticles by using Plackett-Burman screening design. Adv Sci Lett, 2014;20:923–32.
   Google Scholar
• Rahman Z, Zidan AS, Khan MA. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur J Pharm Biopharm, 2010;76:127–37.
   PubMed Web of Science ®Google Scholar
• Ranpise NS, Korabu SS, Ghodake VN. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Colloids Surf B Biointerfaces, 2014;116:81–7.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res, 2007;24:2198–06.
   PubMed Web of Science ®Google Scholar
• Schipper N, Olsson S, Hoogstraate J, deBoer AG, Varum KM, Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm Res, 1997;14:923–9.
   PubMed Web of Science ®Google Scholar
• Schubert MA, Müller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles evaluation of the method and process parameters. Eur J Pharm Biopharm, 2003;55:125–31.
   PubMed Web of Science ®Google Scholar
• Seremeta KP, Reyes Tur MI, Pérez SM, Höcht C, Taira C, Hernández ODL, Sosnik A. Spray-dried didanosine-loaded polymeric particles for enhanced oral bioavailability. Colloids Surf B, 2014;123:515–23.
   PubMed Web of Science ®Google Scholar
• Singh S, Dobhal AK, Jain A, Pandit JK,S, Chakraborty S. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine. Chem Pharm Bull, 2010;58:650–5.
   PubMed Web of Science ®Google Scholar
• Solanki AB, Parikh JR, Parikh RH. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design. AAPS Pharm Sci Tech, 2007;8:E1–7.
   PubMed Web of Science ®Google Scholar
• Sowjanya P, Srinath N, Sumanth KS, Chaitanya D, Sai AP, Padmaja V. Validated RP-HPLC method for estimation of sodium cromoglycate in human plasma. Int J Pharm Res Dev, 2013;5:112–20.
   Google Scholar
• Tariq M, Alam MA, Singh AT, Iqbal Z, Panda AK, Talegaonkar S. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations. Colloids Surf B, 2015;128:448–56.
   PubMed Web of Science ®Google Scholar
• Trevaskis NL, Charman WN, Porter CJH. Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update. Adv Drug Deliv Rev, 2008;60:702–16.
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Sarmento B, Carvalho RA, Neufeld RJ, Veiga F. Facilitated nanoscale delivery of insulin across intestinal membrane models. Int J Pharm, 2011;412:123–31.
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Loveymi BD, Jelvehgari M, Valizadeh H. The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system. Colloids Surf B Biointerfaces, 2013;103:174–81.
   PubMed Web of Science ®Google Scholar